• No results found

The role of cardiac microvascular endothelial cells in drug induced cardiovascular toxicity

N/A
N/A
Protected

Academic year: 2019

Share "The role of cardiac microvascular endothelial cells in drug induced cardiovascular toxicity"

Copied!
273
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Figure 1.2.  Cardiac progenitor cells and their lineage.  Endothelial and hematopoietic lineages form from a hemangioblast which originates from precardiac mesoderm
Figure 1.3.  Structure of vasculature.  A. Macrovasculature is comprised of tunica intima surrounded by basement membrane, tunica media and tunica adventia
Figure 1.4.  Vasculogenesis and angiogensis following stem cell differentiation.  Endothelial cells are able to form a vascular plexus following differentiation which leads to formation of new blood vessels, termed vasculogenesis
Figure 1.5.  Tumour neovascularisation.  The formation of vascular in tumours forms mainly from angiogenesis
+7

References

Related documents

That is, results obtained from the study have clearly shown that sustained growth and development in start-up SMMEs that operate in the City of Tshwane is affected significantly

SEP OCT NOV DEC JAN FEB MAR APR MAY JUN JUL AUG Reform  Priorities  Point  Persons Parter  Support.. 2.1  Improving  the  private  sector  investment

On the other hand, the results also shown that most of respondents affirmed that agricultural innovation was the majority of information need, farming technique, pest

Asymptomatic carriage of P. jiroveci was shown by detection of P. jiroveci DNA in a BAL fluid sample only by nested PCR at the mt LSU rRNA locus. Not all of these patients

Fourth, proving that ideology significantly matters to the fates of judicial nominations is complicated by the fact that Presidents and Senators rarely base their decisions in

enemy.. If the GoYernment of the United States considers that it fulfills its duty as a neutral nation by confining th · e ad1nission of anned merchant ships

Objective: The uroselective α -blocker silodosin significantly improved International Prostate Symptom Score (IPSS) in two 12-week, double-blind (DB), placebo-controlled Phase